Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How is alpha‐synuclein cleared from the cell?
Leonidas Stefanis, Evangelia Emmanouilidou, Marina Pantazopoulou, et al.
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 577-590
Open Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

Parkinson disease and the immune system — associations, mechanisms and therapeutics
Eng‐King Tan, Yinxia Chao, Andrew B. West, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 6, pp. 303-318
Closed Access | Times Cited: 361
The emerging role of α-synuclein truncation in aggregation and disease
Zachary A. Sorrentino, Benoit I. Giasson
Journal of Biological Chemistry (2020) Vol. 295, Iss. 30, pp. 10224-10244
Open Access | Times Cited: 139
Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo
Debashis Dutta, Malabendu Jana, Moumita Majumder, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 118
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Luís M. A. Oliveira, Thomas Gasser, Robert H. Edwards, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 114
Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches
Marija Vidović, Milena Rikalović
Cells (2022) Vol. 11, Iss. 11, pp. 1732-1732
Open Access | Times Cited: 90
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Bruna Araújo, Rita Caridade-Silva, Carla Guedes, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2908-2908
Open Access | Times Cited: 85
SH-SY5Y Cell Line In Vitro Models for Parkinson Disease Research—Old Practice for New Trends
Octavian Costin Ioghen, Laura Cristina Ceafalan, Bogdan Popescu
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 65
Neuron-Astrocyte Interactions in Parkinson’s Disease
Ikuko Miyazaki, Masato Asanuma
Cells (2020) Vol. 9, Iss. 12, pp. 2623-2623
Open Access | Times Cited: 120
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 109
Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation
Rita Marreiros, Andreas Müller‐Schiffmann, Svenja V. Trossbach, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 12, pp. 6741-6751
Open Access | Times Cited: 107
Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease
Brit Mollenhauer, Chelsea Caspell‐Garcia, Christopher S. Coffey, et al.
Movement Disorders (2019) Vol. 34, Iss. 9, pp. 1354-1364
Open Access | Times Cited: 102
Innate and adaptive immune responses in Parkinson's disease
Aubrey M. Schonhoff, Gregory P. Williams, Zachary D. Wallen, et al.
Progress in brain research (2019), pp. 169-216
Open Access | Times Cited: 88
Determinants of seeding and spreading of α-synuclein pathology in the brain
Martin T. Henrich, Fanni F. Geibl, Lakshminarasimhan Harini, et al.
Science Advances (2020) Vol. 6, Iss. 46
Open Access | Times Cited: 81
Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies
Fiona Limanaqi, Francesca Biagioni, Stefano Gambardella, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 3028-3028
Open Access | Times Cited: 72
Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation
Gaetano Calabrese, Cristen Molzahn, Thibault Mayor
Journal of Biological Chemistry (2022) Vol. 298, Iss. 7, pp. 102062-102062
Open Access | Times Cited: 61
Expanding the role of proteasome homeostasis in Parkinson’s disease: beyond protein breakdown
Mingxia Bi, Xixun Du, Qian Jiao, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 60
Contribution of proteases to the hallmarks of aging and to age‐related neurodegeneration
Mamta Rai, Michelle Curley, Zane Coleman, et al.
Aging Cell (2022) Vol. 21, Iss. 5
Open Access | Times Cited: 39
Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease
Mia Horowitz, Hila Braunstein, Ari Zimran, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114402-114402
Closed Access | Times Cited: 38
Biogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases
Yuguo Yuan, Jialin Wang, Yaxin Zhang, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3177-3210
Open Access | Times Cited: 38
Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
Satra Nim, Darren M. O’Hara, Carles Corbi‐Verge, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Research Priorities on the Role of α‐Synuclein in Parkinson's Disease Pathogenesis
Jacqueline Burré, Robert H. Edwards, Glenda M. Halliday, et al.
Movement Disorders (2024) Vol. 39, Iss. 10, pp. 1663-1678
Open Access | Times Cited: 8
Exosome Production Is Key to Neuronal Endosomal Pathway Integrity in Neurodegenerative Diseases
Paul M. Mathews, Efrat Levy
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 65
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
Somin Kwon, Michiyo Iba, Changyoun Kim, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 3, pp. 935-954
Open Access | Times Cited: 64
Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective
François Le Guerroué, Richard J. Youle
Cell Death and Differentiation (2020) Vol. 28, Iss. 2, pp. 439-454
Open Access | Times Cited: 64
Autophagy in Astrocytes and its Implications in Neurodegeneration
Katherine Sung, María Jiménez-Sánchez
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2605-2621
Closed Access | Times Cited: 62
Page 1 - Next Page

Scroll to top